Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
Joint Authors
Agasthi, Pradyumna
Narayanasamy, Hemalatha
Sorajja, Dan
Slack, James
Mookadam, Farouk
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-09-30
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia.
We present a case of cardiomyopathy associated with decitabine used for secondary acute myelogenous leukemia.
The patient presented with new heart failure symptoms and an ejection fraction decline.
American Psychological Association (APA)
Agasthi, Pradyumna& Narayanasamy, Hemalatha& Sorajja, Dan& Slack, James& Mookadam, Farouk. 2018. Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy. Case Reports in Cardiology،Vol. 2018, no. 2018, pp.1-4.
https://search.emarefa.net/detail/BIM-1140906
Modern Language Association (MLA)
Agasthi, Pradyumna…[et al.]. Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy. Case Reports in Cardiology No. 2018 (2018), pp.1-4.
https://search.emarefa.net/detail/BIM-1140906
American Medical Association (AMA)
Agasthi, Pradyumna& Narayanasamy, Hemalatha& Sorajja, Dan& Slack, James& Mookadam, Farouk. Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy. Case Reports in Cardiology. 2018. Vol. 2018, no. 2018, pp.1-4.
https://search.emarefa.net/detail/BIM-1140906
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1140906
